Morgan Stanley Sticks to Its Hold Rating for Heidelberg Materials (0MG2)
In a report released on May 29, Cedar Ekblom from Morgan Stanley maintained a Hold rating on Heidelberg Materials (0MG2 – Research Report), with a price target of €148.00.
Confident Investing Starts Here:
Ekblom covers the Industrials sector, focusing on stocks such as Buzzi SpA, DHL Group, and Heidelberg Materials. According to TipRanks, Ekblom has an average return of 5.3% and a 56.40% success rate on recommended stocks.
In addition to Morgan Stanley, Heidelberg Materials also received a Hold from UBS's Marcus Cole in a report issued on May 28. However, yesterday, Berenberg Bank maintained a Buy rating on Heidelberg Materials (LSE: 0MG2).
Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is neutral on the stock.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 hours ago
- CNBC
Here are Friday's biggest analyst calls: Tesla, Nvidia, Robinhood, Microsoft, Deere, Amazon, McDonald's & more
Here are Friday's biggest calls on Wall Street: Morgan Stanley reiterates Tesla as a top pick Analyst Adam Jonas said he's sticking with Tesla despite the stock's volatility. "When putting our trading cap on, we have higher conviction in near-term volatility than near-term direction. We reiterate our $410 price target but are prepared for the stock to give up more than just the 4 weeks of performance it has sacrificed so far." KeyBanc initiates Twilio and Five9 as overweight KeyBanc said both stocks are well positioned for growth. "We are initiating both FIVN and TWLO at Overweight ratings. For different reasons, these two are outgrowing the rest of the cohort and yet we feel the stocks do not currently reflect the opportunity for this enhanced growth to continue." UBS upgrades Teradata to neutral from sell UBS said it's seeing "some signs of stabilization." "After speaking with ~15 customers/partners, we resume coverage at Neutral (from Sell) as we conclude the outlook for Teradata is still challenging but much of this appears to be priced in and we did pick up some signs of stabilization." Bank of America reiterates Broadcom as buy Bank of America said the stock remains a top pick following earnings on Thursday. "We rate Broadcom Buy due to its high-quality diversified exposure to secular product cycles in the smartphone, cloud data center, telecom and enterprise storage markets." Goldman Sachs initiates Teva as buy Goldman initiates the biopharma company with a buy on Friday and said the stock's valuation is compelling. "We initiate coverage of generic pharmaceutical stocks, with Buy ratings on TEVA and AMRX and a Neutral rating on VTRS. Overall, acknowledging recent volatility on both micro (e.g., FY25 guides) and macro (e.g., tariff and drug pricing policy) factors, we believe the group offers opportunities for exposure (at undemanding valuations." Read more about this call here. Bernstein downgrades CrowdStrike to market perform from outperform Bernstein downgraded the stock on valuation. " CrowdStrike is VERY expensive vs. our $371 PT, and this is a cybersecurity wide phenomenon." Morgan Stanley reiterates Amazon as overweight Morgan Stanley called Amazon an "under-appreciated GenAI winner." "AMZN's push into humanoid delivery another sign of GPU enabled advances set to drive more durable market share gains and FCF/order. Between fulfillment and delivery AMZN is now investing to automate $200bn of Logistics Costs. Remain OW for this under-appreciated GenAI winner." Goldman Sachs upgrades MasTec to buy from neutral Goldman said the infrastructure company has "significant new pipeline construction opportunities ahead." "We are upgrading MTZ to Buy and lowering MYRG to Neutral. While we continue to believe that both stocks will benefit from strong utility spending, the potential for estimate revisions is stronger at MTZ given the significant new pipeline construction opportunities ahead." Goldman Sachs reiterates Robinhood as buy Goldman raised its price target on the stock to $81 per share from $72. "We view the recent monthly data for HOOD positively, and remain constructive on the structural growth of the business and the retail trading backdrop." Barclays upgrades Ormat Technologies to overweight from equal weight Barclays said the geothermal energy company is a "winner" in the tax bill. "Geothermal emerged a winner from the proposed tax bill and will benefit from 'all of the above' solution with the US facing a severe power deficit over the next 5 years. Defensive in the near term with little earnings risk, Ormat should steadily capture higher PPA [power purchase agreement] pricing while expanding capacity." Barclays initiates Solaris Energy as overweight Barclays said the energy infrastructure company is a data center player. "With data centers creating an acute power gap, increasing with every new announcement, Solaris is the leading player in off-grid Distributed Power solutions, benefiting from higher electricity rates and the need for speed-to-power solutions." Morgan Stanley upgrades Applied Materials to equal weight from underweight Morgan Stanley says shares of Applied Materials are now "partially derisked." "Tough FY26 set up but partially derisked; Upgrade to EW." Jefferies upgrades Urban Outfitters to hold from underperform Jefferies said it sees a more balanced risk/reward. "Following URBN's healthy 1Q and ahead of an investor event next week, we are moving to Hold." Goldman Sachs reiterates Tesla as neutral The firm lowered its price target on the stock to $285 per share from $295 in its Tesla deliveries preview. "We believe 2Q deliveries could end up between 335K and 395K depending on how strong June results are (with factors including the degree of incentives Tesla utilizes), and our base case view is now 365K deliveries for 2Q25." Loop downgrades McDonald's to hold from buy Loop said the chicken strips launch has largely been a negative. "We are downgrading MCD to HOLD this morning given growing concerns the company's domestic comp growth profile will not rebound as much as expected over the remainder of 2025." Bernstein reiterates Microsoft as outperform The firm raised its price target on the stock to $540 per share from $520. " Microsoft's partnership with OpenAI can generate huge potential revenue upside for Azure by 2029/30, if OpenAI's projection turns into reality." UBS reiterates Nvidia as buy UBS said the stock remains a top idea. "In the US, we continue to prefer AVGO, MRVL, ARM, MU, NVDA, and TXN." Melius upgrades Deere to buy from hold Melius said Deere has a "leading position in ag tech. "After one to two years on the sidelines, we are returning to our Buy rating, and raising our two-year target price to $750. The timeline to cyclical recovery and to the market's appreciation for Deere's extraordinary position is still uncertain." Morgan Stanley upgrades MP Materials to overweight from equal weight Morgan Stanley said the rare earths company is well positioned for humanoids. "Geopolitical and trade tensions are finally pushing critical mineral supply chains to top of mind. MP is the most vertically integrated rare earths company ex-China. We upgrade MP to OW."
Yahoo
4 hours ago
- Yahoo
Global's Top Penny Stocks To Watch In June 2025
Global markets have been navigating a complex landscape, with U.S. stocks showing resilience amid trade policy uncertainties and inflation easing to its slowest pace in four years. Against this backdrop, investors might find opportunities in penny stocks—an investment area that, despite its somewhat outdated name, remains relevant for those seeking growth potential in smaller or newer companies. These stocks can offer surprising value when backed by strong financial health, presenting a mix of value and growth that larger firms might overlook. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$71.94M ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$725.59M ★★★★★★ Foresight Group Holdings (LSE:FSG) £3.96 £445.67M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.61 SEK270.7M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$453.46M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$716.16M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.31 SGD9.09B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.15B ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Click here to see the full list of 5,587 stocks from our Global Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Shenzhen Asia Link Technology Development Co., Ltd. operates in the technology sector with a market capitalization of CN¥1.66 billion. Operations: No specific revenue segments have been reported for this company. Market Cap: CN¥1.66B Shenzhen Asia Link Technology Development Co., Ltd. is navigating the penny stock landscape with a market cap of CN¥1.66 billion, demonstrating resilience through its substantial cash runway exceeding three years at current free cash flow levels. Despite being unprofitable with negative return on equity, it has reduced losses by 24.7% annually over five years and boasts a seasoned management team and board of directors. Recent earnings reveal improved financial performance, with Q1 2025 revenues rising to CN¥104.95 million from CN¥83.29 million year-over-year, indicating potential growth amidst existing short-term liabilities challenges and stable debt levels relative to assets. Unlock comprehensive insights into our analysis of Shenzhen Asia Link Technology DevelopmentLtd stock in this financial health report. Gain insights into Shenzhen Asia Link Technology DevelopmentLtd's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Guizhou Bailing Group Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development, production, and sale of traditional Chinese medicine products, with a market cap of CN¥5.65 billion. Operations: No specific revenue segments have been reported for the company. Market Cap: CN¥5.65B Guizhou Bailing Group Pharmaceutical Co., Ltd. is navigating financial challenges with a market cap of CN¥5.65 billion, having recently turned profitable despite a significant earnings decline over five years. The company reported Q1 2025 revenues of CN¥760.59 million, down from the previous year, and net income of CN¥24.17 million. Its debt management shows improvement with a reduced debt-to-equity ratio and satisfactory net debt levels supported by operating cash flow covering 23% of its debt. However, short-term liabilities match short-term assets, posing liquidity concerns amidst stable weekly volatility and experienced management oversight. Jump into the full analysis health report here for a deeper understanding of Guizhou Bailing Group Pharmaceutical. Examine Guizhou Bailing Group Pharmaceutical's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Hainan RuiZe New Building Material Co., Ltd operates in China, focusing on the production and sale of commercial concrete and municipal sanitation services, with a market cap of CN¥3.98 billion. Operations: The company generates revenue primarily from its operations in China, amounting to CN¥1.23 billion. Market Cap: CN¥3.98B Hainan RuiZe New Building Material Co., Ltd, with a market cap of CN¥3.98 billion, faces financial challenges as it remains unprofitable with increasing losses over the past five years. Despite reporting sales of CN¥1.28 billion for 2024, revenue declined from the previous year, and net losses persisted at CN¥241.53 million. The company's high net debt to equity ratio of 175.8% raises concerns about its financial leverage, although it maintains a stable cash runway due to positive free cash flow growth. Additionally, short-term assets exceed both short and long-term liabilities, providing some balance sheet strength amidst volatility stability. Navigate through the intricacies of Hainan RuiZe New Building MaterialLtd with our comprehensive balance sheet health report here. Learn about Hainan RuiZe New Building MaterialLtd's historical performance here. Take a closer look at our Global Penny Stocks list of 5,587 companies by clicking here. Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SZSE:002316 SZSE:002424 and SZSE:002596. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
5 hours ago
- Yahoo
Morgan Stanley Sees More Inflows Into Chinese Equities
Morgan Stanley's Laura Wang discusses her outlook for Chinese equities on Bloomberg Television. Wang says a weaker US dollar is "positive" for China's stock markets and adds that the firm expects more inflows in the next six to 12 months.
